CoChat

Vitamin B12 Status in the Elderly as Judged by Available Biochemical Markers

Obeid, Rima, Schorr, Heike, Eckert, Rudolf, Herrmann, Wolfgang · 2004 · Clinical Chemistry
Cited by 97

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Deficiencies of vitamin B12, B6, and folate are frequent in elderly individuals (1)(2)(3)(4), with estimated prevalences in elderly individuals of 5–40% depending on the marker for deficiency and the cutoff used (1)(2)(3)(4). Detection of a subnormal status of these B vitamins has considerable importance. Vitamin B12 deficiency in the elderly may cause cognitive dysfunction (5), neuropsychiatric disorders, dementia (6), and hyperhomocysteinemia(5), an independent risk factor for coronary vascular disease and dementia (7)(8). A 5 μmol/L increment in total plasma homocysteine (tHcy) has been associated with a 49% increase in all-cause of mortality among individuals 65–72 years of age (9). The measurement of total vitamins in serum has a limited sensitivity and specificity, especially in individuals with serum vitamin B12 <300 pmol/L (1)(3). More specific and sensitive biochemical approaches have been developed recently (10)(11). Among the biochemical markers whose concentrations are increased in vitamin B12-deficient individuals are methylmalonic acid (MMA) and tHcy, which is also increased in deficiencies of folate and vitamin B6 (1)(10). Increased MMA and tHcy have been observed in elderly individuals in spite of serum concentrations of the B vitamins within the appropriate reference intervals (1)(2). High concentrations of these metabolites were decreased by supplementation with B vitamins, which suggests pretreatment deficiency (12)(13)(14). The current study was undertaken to investigate vitamin B12 status in a group of elderly Germans, as determined by some available biochemical markers. The study population comprised 228 individuals > 65 years of age. We recruited 109 free-living elderly individuals [mean (SD) age, 79 (10) years] through use of a general practitioner’s register and 119 elderly individuals [82 ( (6)) years] who were institutionalized for 6 weeks for recovery from various illnesses. All were in good general condition with no acute diseases. Exclusion criteria included vitamin consumption, life-threatening illness, serious malignancies, renal insufficiency, recent myocardial infarction, or cerebrovascular event. Diabetes mellitus, hypertension, chronic heart failure, and history of coronary vascular disease were found in 18%, 38%, 43%, and 26%, respectively. A group of apparently healthy younger adults who did not take vitamins [n = 74; mean (SD) age, 43 (17) years] was also studied. Fasting blood was drawn into tubes without anticoagulant. Blood samples were immediately placed on ice and centrifuged within 45 min at 2000g and 4 °C. Serum was separated and stored at −70 °C for further analyses. Serum concentrations of tHcy, MMA, and cystathionine were measured by gas chromatography–mass spectrometry as described elsewhere (1). The CV for tHcy, MMA, and cystathionine assays were 3.2%, 5.3%, and 5.8%, respectively. Serum concentrations of folate and vitamin B12 were measured by a chemiluminescence immunoassay (ADVIA Centaur; Bayer). The concentration of holotranscobalamin (holoTC) was assayed by RIA (Axis-Shield) (15). The CV for holoTC assay were 8.0% and 5.0% at 38 and 98 pmol/L, respectively. Serum concentrations of vitamin B6 (pyridoxal 5-phosphate) were measured by HPLC with fluorescence detection using reagents from Immundiagnostik. The CV for the vitamin B6 assay was 7.5% at 32 nmol/L. The data analyses were performed with SPSS (Ver. 11.0 for Windows). Categorical variables were compared by the χ2 test. One-way ANOVA and the post hoc Tamhane-T2 tests were applied for multiple comparisons. The odds ratios for pathologically increased or decreased markers among two ranges of serum creatinine were calculated by logistic regression analysis. Logarithmic transformation was applied where appropriate. Correlations between different markers were assessed by the Spearman test. P values <0.05 were regarded as significant. Increased concentrations of the metabolites or a decreased concentration of the vitamin was considered as that ≥95% or ≤5%, respectively, of the data in the younger individuals. Increased serum creatinine was considered as >79.6 and 106.1 μmol/L for females and males, respectively. The concentrations of the metabolites and the B vitamins are shown in Table 1 according to age. The concentrations of tHcy, MMA, and cystathionine were highest in individuals >80 years. Individuals >80 years had the lowest median vitamin B12, B6, and folate concentrations. Median holoTC was only slightly lower in individuals >80 years compared with those ≤65 years. The incidence of increased concentrations of the metabolites increased with age, whereas the prevalence of a decreased holoTC was only slightly increased with increasing age (Table 1 ). Median concentrations of tHcy, holoTC, and vitamin B12 are shown according to age and intergroup quartiles of MMA (Fig. 1 in the Data Supplement that accompanies the online version of this Technical Brief athttp://www.clinchem.org/content/vol50/issue1/).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1373/clinchem.2003.021717

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 97

Metadata

Authors
Obeid, R., Schorr, H., Eckert, R., & Herrmann, W.
Venue
Clinical Chemistry
Published
2004-01-01
Volume
50
Issue
1
Pages
238-241
ISSN
  • 0009-9147 (ISSN-L)
  • 1530-8561
OpenAlex
W2097572673
Cited by
97
References
2
FWCI
3.68
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.